e-learning
resources
Madrid 2019
Monday, 30.09.2019
Involvement of the environment and inflammation in pulmonary remodelling
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multi-walled carbon nanotubes elicit sustained pulmonary remodelling depending on gender rather than a functional Nrf2 status
A. Boots (Maastricht, Netherlands), C. Albrecht (Duesseldorf, Germany), F. Van Schooten (Maastricht, Netherlands), R. Schins (Duesseldorf, Germany)
Source:
International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Session:
Involvement of the environment and inflammation in pulmonary remodelling
Session type:
Thematic Poster
Number:
2441
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boots (Maastricht, Netherlands), C. Albrecht (Duesseldorf, Germany), F. Van Schooten (Maastricht, Netherlands), R. Schins (Duesseldorf, Germany). Multi-walled carbon nanotubes elicit sustained pulmonary remodelling depending on gender rather than a functional Nrf2 status. 2441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Enhanced adverse health effects upon in vivo exposure to multi-walled carbon nanotubes in chronic obstructive pulmonary disease
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Probing the carcinogenic potential of carbon nanotubes
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Effect of surface functionalisation on the interaction of carbon nanotubes with primary human alveolar cells in vitro.
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Airway region-specific effects of carbon black nanoparticles (CBNP)
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Inhalation of carbon nanotubes will not necessarily induce mesothelioma: the two faces of Janus
Source: Annual Congress 2010 - Mesothelioma and engineered nanotubes: cause for concern?
Year: 2010
The effect of ferric oxide nanoparticles on pulmonary morphology, redox system and some immune components
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
Lung inflammation promotes arterial thrombosis
via
P-selectin: a study with carbon nanotubes in mice
Source: Eur Respir J 2006; 28: Suppl. 50, 618s
Year: 2006
The TL,NO/TL,CO ratio in pulmonary function test interpretation
Source: Eur Respir J 2013; 41: 453-461
Year: 2013
Predicting survival in COPD using the transfer factor for carbon monoxide Z-score
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 963-965
Year: 2014
The lung and carbon dioxide: implications for permissive and therapeutic hypercapnia
Source: Eur Respir J 2002; 20: 6-11
Year: 2002
Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level
Source: Eur Respir J 2013; 41: 489
Year: 2013
Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD
Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020
Year: 2021
The acute impact of exercise test on exhaled carbon monoxide rate
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
Impact of atrial septal defect closure on diffusing capacity for nitric oxide and carbon monoxide
Source: ERJ Open Res, 5 (2) 00260-2018; 10.1183/23120541.00260-2018
Year: 2019
The relationship between transfer coefficient for carbon monoxide (KCO), weight and biochemical and morphological parameters in pulmonary emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept